Related Experiment Video
Updated: Jul 19, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide
Jeffrey W H Fung1, Q Zhang, Gabriel W K Yip
1Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China. jwhfung@cuhk.edu.hk
Insights
Cardiac resynchronization therapy (CRT) significantly improved left ventricular (LV) function and reduced heart failure severity in patients with moderate LV systolic dysfunction. Further research is recommended for less severe heart failure cases.
Area of Science:
- Cardiology
- Heart Failure Management
- Medical Devices
Background:
- Moderate left ventricular (LV) systolic dysfunction poses a significant challenge in heart failure management.
- Optimizing treatment for patients with New York Heart Association (NYHA) class III and specific echocardiographic parameters is crucial.
Purpose of the Study:
- To investigate the impact of cardiac resynchronization therapy (CRT) on disease progression in patients with moderate LV systolic dysfunction.
- To evaluate the effects of CRT on LV remodeling and heart failure symptoms.
Main Methods:
- A prospective study involving 15 patients with NYHA class III, LV ejection fraction >35% and <45%, and QRS duration >120 msec.
- Echocardiographic and standard heart failure assessments were performed before and 3 months after CRT implantation.
- Comparison with 30 matched patients receiving conventional CRT.
Main Results:
- Significant reductions in LV end-systolic and end-diastolic volumes were observed post-CRT.
- Improvement in LV ejection fraction and NYHA class was significant.
- No difference in LV volumes, ejection fraction, or exercise capacity compared to the conventional group, but a greater quality of life improvement in the conventional group.
Conclusions:
- CRT demonstrated significant LV reverse remodeling in patients with moderate LV systolic dysfunction and wide QRS complex.
- The findings suggest potential benefits of CRT in this patient subgroup.
- Further studies are warranted to explore CRT's benefits in patients with less severe heart failure.
Background:
We sought to investigate the effect of cardiac resynchronization therapy (CRT) on disease progression in patients with moderate left ventricular (LV) systolic dysfunction.
Methods And Results:
This is a prospective study to explore the effect of CRT in 15 optimally treated patients (age: 66.1 +/- 12.8 years; male = 13) with New York Heart Association (NYHA) class III, LV ejection fraction >35% and <45% and QRS duration >120 msec. Echocardiographic examination and standard heart failure assessment was performed before and 3 months after CRT implantation. The magnitude of echocardiographic remodeling measurements was compared with 30 age, sex, NYHA class, and heart failure etiology matched patients with conventional CRT indication. There were significant reductions in LV end-systolic (86.2 +/- 24.1 to 69.7 +/- 22.2 mL, P < 0.01)/end-diastolic (135.5 +/- 36.8 to 120.5 +/- 34.6 mL, P < 0.01) volumes, improvement in LV ejection fraction (39.1 +/- 2.2 to 44.2 +/- 5.5%, P = 0.01), and NYHA class (3.0 +/- 0.0 to 2.07 +/- 0.46, P < 0.001). There was no difference in changes in LV volumes, ejection fraction, NYHA class, and exercise capacity before and after CRT between the study and conventional groups except for greater improvement in the quality of life score in the conventional group.
Conclusion:
In this prospective study, significant LV reverse remodeling by CRT in those with a wide QRS complex and moderate LV systolic dysfunction was observed. Further studies to explore the benefit of CRT in patients with less severe heart failure are recommended.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
